Chanel (Chengyuan) Press is a seasoned professional in science and health policy, currently serving as the Director of Regulatory Affairs at Breakthrough T1D since 2024. They previously held roles as a Science Policy Analyst at the FDA and a Health Science Officer at the U.S. Department of Veterans Affairs in 2024. With experience as a Research Fellow at the Physicians Committee for Responsible Medicine and a Postdoctoral Research Fellow at the National Cancer Institute, they possess extensive expertise in patient-focused drug development and emerging biotechnologies. Chanel earned their Ph.D. in Pharmacology and Toxicology from the University of Kansas in 2012.
This person is not in the org chart
This person is not in any teams
This person is not in any offices